| Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6 months S Llufriu, J Castillo, Y Blanco, L Ramio-Torrenta, J Rio, M Valles, ... Neurology 73 (12), 949-953, 2009 | 214 | 2009 |
| Effectiveness and safety of tranexamic acid administration during total knee arthroplasty M Lozano, M Basora, L Peidro, I Merino, JM Segur, A Pereira, F Salazar, ... Vox sanguinis 95 (1), 39-44, 2008 | 167 | 2008 |
| CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients E Carreras, A Saiz, P Marín, C Martínez, M Rovira, N Villamor, ... haematologica 88 (3), 306-314, 2003 | 143 | 2003 |
| Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial I Zubizarreta, G Flórez-Grau, G Vila, R Cabezón, C España, M Andorra, ... Proceedings of the National Academy of Sciences 116 (17), 8463-8470, 2019 | 138 | 2019 |
| Platelet activation In mice and human Helicobacter pylori infection. JI Elizalde, J Gómez, J Panés, M Lozano, M Casadevall, J Ramírez, ... The Journal of Clinical Investigation 100 (5), 996-1005, 1997 | 127 | 1997 |
| Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor: experience from an academic phase I clinical trial M Castella, M Caballero-Baños, V Ortiz-Maldonado, ... Frontiers in immunology 11, 482, 2020 | 112 | 2020 |
| Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center E Carreras, F Fernández-Avilés, L Silva, M Guerrero, CF De Larrea, ... Bone marrow transplantation 45 (9), 1417-1422, 2010 | 106 | 2010 |
| CART19-BE-01: a multicenter trial of ARI-0001 cell therapy in patients with CD19+ relapsed/refractory malignancies V Ortíz-Maldonado, S Rives, M Castellà, A Alonso-Saladrigues, ... Molecular Therapy 29 (2), 636-644, 2021 | 105 | 2021 |
| Development of a novel anti-CD19 chimeric antigen receptor: a paradigm for an affordable CAR T cell production at academic institutions M Castella, A Boronat, R Martín-Ibáñez, V Rodríguez, G Suñé, ... Molecular Therapy-Methods & Clinical Development 12, 134-144, 2019 | 103 | 2019 |
| Complement activation and thrombotic microangiopathies M Palomo, M Blasco, P Molina, M Lozano, M Praga, S Torramade-Moix, ... Clinical Journal of the American Society of Nephrology 14 (12), 1719-1732, 2019 | 76 | 2019 |
| International Forum regarding practices related to donor haemoglobin and iron M Goldman, K Magnussen, J Gorlin, M Lozano, J Speedy, A Keller, J Pink, ... Vox sanguinis 111 (4), 449-455, 2016 | 61 | 2016 |
| Platelet count and mean platelet volume in the Spanish population M Lozano, J Narvaez, A Faundez, R Mazzara, J Cid, JM Jou, JL Marín, ... Medicina clinica 110 (20), 774-777, 1998 | 60 | 1998 |
| Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta‐analysis of randomized controlled trials J Cid, G Escolar, M Lozano Vox Sanguinis 103 (4), 322-330, 2012 | 55 | 2012 |
| Effects of Helicobacter pylori Eradication on Platelet Activation and Disease Recurrence in Patients with Acute Coronary Syndromes JI Elizalde, S Pérez‐Pujol, M Heras, A Sionis, N Casanovas, T Martorell, ... Helicobacter 9 (6), 681-689, 2004 | 55 | 2004 |
| International Forum on GMP-grade human platelet lysate for cell propagation: summary D Strunk, M Lozano, DC Marks, YS Loh, G Gstraunthaler, H Schennach, ... Vox Sang 113 (1), 80-87, 2018 | 51 | 2018 |
| Platelet activation in mice and human JI Elizalde, J Gomez, J Panes, M Lozano, M Casadevall, J Ramirez, ... Helicobacter pylori, 996-1005, 0 | 50 | |
| Plasma exchange: an effective rescue therapy in critically ill patients with coronavirus disease 2019 infection J Fernandez, J Gratacos-Ginès, P Olivas, M Costa, S Nieto, D Mateo, ... Critical care medicine 48 (12), e1350-e1355, 2020 | 47 | 2020 |
| Effects of the addition of second‐messenger effectors to platelet concentrates separated from whole‐blood donations and stored at 4° C or–80° C M Lozano, G Escolar, R Mazzara, J Connor, JG White, C DeLecea, ... Transfusion 40 (5), 527-534, 2000 | 40 | 2000 |
| Prophylactic platelet transfusions RNI Pietersz, HW Reesink, S Panzer, MP Gilbertson, ME Borosak, ... Vox sanguinis, 2012 | 39 | 2012 |
| Risk of Rh (D) alloimmunization after transfusion of platelets from D+ donors to D–recipients J Cid, M Lozano Transfusion 45 (3), 453-453, 2005 | 37 | 2005 |
